B.C. to pay for COVID-19 drug Paxlovid after feds drop coverage – CBC

Recommendations for provincial drug plans feature narrower definition of who should qualify

May 30, 2024

British Columbia will cover the cost of an antiviral drug aimed at treating mild to moderate cases of COVID-19 as the federal government ends its coverage.

A statement from B.C.’s Health Ministry says the province will provide 100 per cent coverage for the treatment sold under the brand name Paxlovid, for B.C. residents with an active medical services plan.

A provincial government web page says the change took effect on Tuesday, after the federal government stopped supplying Paxlovid in March, and pharmacies are to obtain Paxlovid supplies from their wholesaler.

The Health Ministry says the drug is recommended for people at higher risk of serious illness and hospitalization due to COVID-19, such as those who are immunocompromised.

It says treatment with Paxlovid must begin within five days of the start of symptoms to be effective and can help prevent symptoms getting worse.

The ministry adds that a spring booster vaccine for COVID-19 has been available for B.C. residents since early April.

Read more: https://www.cbc.ca/news/canada/british-columbia/paxlovid-coverage-costs-1.7220200

NationTalk Partners & Sponsors Learn More